Physician profile

Amer El-Khatib

Foot & Ankle Surgery · Warren, MI

NPI 1598009540

$407.37

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

See the full distribution for Foot & Ankle Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$188.92

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Smith+Nephew, INC. $136.02 2024 Grafix Pl
Treace Medical Concepts, INC. $129.41 2022-2023
Stryker Corporation $29.03 2022
Organogenesis INC. $27.97 2022
Hydrofera LLC $23.27 2024 Hydrofera Blue Ready - Border
Kci USA, INC. $18.66 2021
Osteomed LLC $15.49 2019
Arthrosurface Incorporated $13.81 2019
Paragon 28, INC. $13.71 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Amer El-Khatib

$407.37

in general payments reported 2019-2025

Years
2019-2024
Top company
Smith+Nephew, INC.

https://glasscript.com/doctor/71629/amer-el-khatib

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.